Skip to main content

MJFF Publications

The Michael J. Fox Foundation continually strives to communicate our scientific progress with the research community — through posters and presentations at meetings, in peer-reviewed scientific publications and with white paper reports.

From
To
  • Default content image

    Multi-pronged Approach to Reposition Drugs for Parkinson’s Disease

    Drug Repositioning Congress - Washington, DC Isradipine. Pioglitazone. Droxidopa.  What do these drugs have in common? They are all approved for other indications and are currently undergoing…
    Learn more

  • Default content image

    Workshop: Understanding the Role of Glucocerebrosidase (GBA1) in Parkinson’s Disease

    New York, NY - Takeaways from a workshop hosted by The Michael J. Fox Foundation to assess the state of GBA-targeted research for Parkinson's disease. Overall, there was a general sense of excitement…
    Learn more

  • Default content image

    Ongoing Development and Characterization of Tools and Resources for Parkinson’s Disease Research

    In recent years, The Michael J. Fox Foundation for Parkinson's Research (MJFF) has endeavored to accelerate progress in Parkinson's disease (PD) research and therapeutic development by decreasing…
    Learn more

  • Default content image

    MJFF Animal Models 2: Phenotypic characterization of the autosomal recessive (Parkin, Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease

    Recessively inherited loss-of-function mutations in the Parkin, DJ-1 or PINK1 gene are linked to familial cases of early-onset Parkinson’s disease (PD).  Single knockout (KO) mice (lacking…
    Learn more

  • Default content image

    MJFF Animal Models I: Generation, Characterization, and Distribution of LRRK2 Animal Models for Parkinson’s Research

    Determining the efficacy of LRRK2 inhibitor therapeutics has been a challenge due to the lack of availability and systematic characterization of LRRK2 animal models.  The existing LRRK2 animal…
    Learn more

  • Default content image

    Critical Targets in Parkinson’s Disease Research

    American Chemical Society - Philadelphia As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation (MJFF) is dedicated to accelerating a cure for Parkinson's…
    Learn more

  • Default content image

    Consortium to Develop an Alpha-Synuclein Imaging Agent

    9th International Symposium on Functional Neuroreceptor Mapping of the Living Brain - Baltimore The Michael J. Fox Foundation (MJFF) is supporting a consortium with the goal of developing a PET…
    Learn more

Articles authored by Rachel Dolhun, MD, a movement disorder specialist on staff at MJFF, offer a practical review of topics related to Parkinson's disease for practicing clinicians.

From
To

No results were found.

Female researcher pipetting in lab.

Breaking Research Updates

Read the latest developments in the field’s understanding and treatment of Parkinson’s disease.

Read Research News
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.